title: Animal models in obesity and hypertension.
abstract: Although obesity is a well-known risk factor for hypertension, the mechanisms by which hypertension develops in obese patients are not entirely clear. Animal models of obesity and their different susceptibilities to develop hypertension have revealed some of the mechanisms linking obesity and hypertension. Adipose tissue is an endocrine organ secreting hormones that impact blood pressure, such as elements of the renin-angiotensin system whose role in hypertension have been established. In addition, the appetite-suppressing adipokine leptin activates the sympathetic nervous system via the melanocortin system, and this activation, especially in the kidney, increases blood pressure. Leptin secretion from adipocytes is increased in most models of obesity due to leptin resistance, although the resistance is often selective to the anorexigenic effect, while the susceptibility to the hypertensive effect remains intact. Understanding the pathways by which obesity contributes to increased blood pressure will hopefully pave the way to and better define the appropriate treatment for obesity-induced hypertension.
authors.affiliation: Institute of Endocrinology, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, 52521, Israel. gabriella.lieberman@sheba.health.gov.il
authors.forename: Gabriella
authors.initials: G
authors.lastname: Segal-Lieberman
authors.forename: Talma
authors.initials: T
authors.lastname: Rosenthal
mesh_terms: D000818:Animals; D001794:Blood Pressure / Q000502:physiology; D004195:Disease Models, Animal; D006801:Humans; D006973:Hypertension / Q000378:metabolism* / Q000503:physiopathology; D020738:Leptin / Q000378:metabolism; D009765:Obesity / Q000378:metabolism* / Q000503:physiopathology; D012084:Renin-Angiotensin System / Q000502:physiology
chemical_list: D020738:Leptin
references.citation: Curr Hypertens Rev. 2010 May 1;6(2):104-209
references.pmid: 21562617
references.citation: Cell Metab. 2010 Nov 3;12(5):431-42
references.pmid: 21035755
references.citation: PLoS One. 2012;7(12):e51334
references.pmid: 23236474
references.citation: J Biochem. 2010 Jul;148(1):115-23
references.pmid: 20413672
references.citation: Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):10085-90
references.pmid: 12897241
references.citation: J Obes. 2013;2013:296537
references.pmid: 23401753
references.citation: Endocrinology. 2012 Apr;153(4):1764-73
references.pmid: 22355066
references.citation: BMC Endocr Disord. 2012 Apr 04;12:3
references.pmid: 22475205
references.citation: Am J Physiol Heart Circ Physiol. 2012 Jul 15;303(2):H197-206
references.pmid: 22610169
references.citation: Circ J. 2010 Jul;74(7):1479-87
references.pmid: 20526041
references.citation: Prog Neurobiol. 2011 Oct;95(2):89-103
references.pmid: 21763394
references.citation: Hypertension. 2012 May;59(5):1069-78
references.pmid: 22493070
references.citation: Diabetes. 2013 Feb;62(2):490-7
references.pmid: 23048186
references.citation: Exp Biol Med (Maywood). 2011 Mar;236(3):309-14
references.pmid: 21345931
references.citation: J Biol Chem. 2010 Jun 4;285(23):17271-6
references.pmid: 20348094
references.citation: Int J Hypertens. 2012;2012:290635
references.pmid: 23316344
references.citation: Curr Opin Nephrol Hypertens. 2013 Mar;22(2):135-40
references.pmid: 23299052
references.citation: Am J Physiol Regul Integr Comp Physiol. 2012 Mar 1;302(5):R561-7
references.pmid: 22204957
references.citation: Hypertension. 2012 Nov;60(5):1280-6
references.pmid: 23033372
references.citation: Curr Hypertens Rep. 2012 Dec;14(6):475-7
references.pmid: 22972530
references.citation: Hypertension. 2011 May;57(5):918-26
references.pmid: 21422382
references.citation: Am J Physiol Regul Integr Comp Physiol. 2012 Jan 15;302(2):R244-51
references.pmid: 22071160
references.citation: J Hypertens. 2011 Apr;29(4):758-62
references.pmid: 21311343
references.citation: Hypertension. 2009 Feb;53(2):387-92
references.pmid: 19029483
references.citation: Med Clin North Am. 2009 May;93(3):733-51
references.pmid: 19427502
references.citation: Am J Hypertens. 2010 Apr;23(4):425-31
references.pmid: 20057360
references.citation: Mol Cell Endocrinol. 2009 Apr 29;302(2):111-7
references.pmid: 19418627
references.citation: Am J Physiol Regul Integr Comp Physiol. 2012 Feb 1;302(3):R313-20
references.pmid: 22049229
references.citation: Biochem Biophys Res Commun. 2012 Feb 17;418(3):559-64
references.pmid: 22293193
references.citation: Peptides. 2009 Nov;30(11):2040-4
references.pmid: 19447150
references.citation: Hypertension. 2012 Dec;60(6):1524-30
references.pmid: 23108647
references.citation: J Appl Physiol (1985). 2012 Dec 15;113(12):1873-83
references.pmid: 23019312
references.citation: Hypertension. 2011 Sep;58(3):479-88
references.pmid: 21788604
references.citation: Exp Physiol. 2013 Feb;98(2):435-43
references.pmid: 22872662
references.citation: Diabetes Obes Metab. 2011 Dec;13(12):1123-9
references.pmid: 21749604
references.citation: Pharmacol Ther. 2013 Mar;137(3):331-40
references.pmid: 23178510